Marinus Pharmaceuticals | MRNS - Ordinary Share Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Marinus Pharmaceuticals

Marinus Pharmaceuticals reported $50K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.


Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
ALKERMES ALKS:US USD 1.72M 25K
Eisai 4523:JP JPY 44.99B 0
Esperion Therapeutics ESPR:US USD 87K 12K
Incyte Corp INCY:US USD 223K 0
Intercept Pharmaceuticals ICPT:US USD 42K 0
Intra Cellular Therapies ITCI:US USD 10K 1000
Marinus Pharmaceuticals MRNS:US USD 50K 0
Minerva Neurosciences NERV:US USD 1000 0
Neurocrine Biosciences NBIX:US USD 100K 0
PTC Therapeutics PTCT:US USD 73K 1000
Sarepta Therapeutics SRPT:US USD 9K 0
Supernus Pharmaceuticals SUPN:US USD 54K 0
UCB UCB:BB EUR 584M 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0